Beta-O2 Technologies Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Beta-O2 Technologies Ltd.
Private Company Edition: Biomedtracker found that 53% of financings during the first quarter were venture capital deals versus 32% in Q1 of last year. Also, Qiming closed a $260m fund, Transition Bio raised a $50m series A round, ProfoundBio completed a $70m series A+ and MycoMedica raised $60m.
The use of virtual, real-time and at-home testing to provide clinical trials data has been steadily gaining the interest of the health care industry. COVID-19 has put this opportunity into sharper focus, says CNS trials technology developer Cambridge Cognition, which is now adding a voice option to its portfolio.
A former employee of Biogen is officially charged in China for allegedly jeopardizing public health, Wuhan tests 10 million residents, India approves remdesivir.
Results from a substudy of EAST2 focused on nodules without a bronchus sign or an airway leading to the nodule shows Broncus' Archimedes system, with proprietary virtual bronchoscopic navigation and "fused fluoroscopy" technology, provides access to nodules located anywhere in the lungs without puncturing the chest wall.
- Medical Devices
- Implantable Devices
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.